Safety study of ME3241 in healthy adults
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good general health (no major medical conditions).
- You weigh more than 45 kg (about 99 pounds) and have a BMI between 18 and 30.
- You have never had a life-threatening infection like sepsis.
- You have never had cancer (including skin cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.